| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2013 | CN102936254A Drug composition containing ceftizoxime sodium compound |
| 02/20/2013 | CN102936252A Sesterterpine compounds, and preparation method and application thereof |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102936249A Halogenated piperazinium compound |
| 02/20/2013 | CN102936233A New crystal form of 1-[di(4- fluorophenyl)methyl]-4-(2,3,4-trimethyl phenyl) piperazine dihydrochloride |
| 02/20/2013 | CN102936212A Guanylhydrazone compounds, compositions, methods of making and using |
| 02/20/2013 | CN102935238A Application of yeast M-dsRNA as TLR3 agonist, and yeast M-dsRNA preparation method |
| 02/20/2013 | CN102935237A Doxorubicin bonding medicine and preparation method thereof |
| 02/20/2013 | CN102935236A Antineoplastic prodrug with P-glycoprotein inhibition function |
| 02/20/2013 | CN102935235A Preparation method of modified casein drug-carrying controlled-release thin film |
| 02/20/2013 | CN102935231A Treatments using citrulline |
| 02/20/2013 | CN102935230A Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer |
| 02/20/2013 | CN102935225A Sterilization agent for sea crab culture and application method thereof |
| 02/20/2013 | CN102935224A Medicinal extract ointment for treating skin scald |
| 02/20/2013 | CN102935221A Anti-aging tablet |
| 02/20/2013 | CN102935188A Traditional Chinese medicine composition for treating candidiasis |
| 02/20/2013 | CN102935169A Externally-applied drug for promoting quick healing of wound |
| 02/20/2013 | CN102935168A Externally applied drug for treating polymyositis |
| 02/20/2013 | CN102935166A Chinese herbal medicine compound fish medicine |
| 02/20/2013 | CN102935158A Externally applied medicine for treating haememorrhoids |
| 02/20/2013 | CN102935127A Traditional Chinese medicine preparation for treating toothache |
| 02/20/2013 | CN102935126A Externally applied medicine for treating burn and scald, and preparation method thereof |
| 02/20/2013 | CN102935119A Method for preparing ointment for treating lumbar disc herniation |
| 02/20/2013 | CN102935109A Compound crossostephium chinense tablet |
| 02/20/2013 | CN102935094A Composite for diabetes |
| 02/20/2013 | CN102935088A Injection therapy and drug constitutes for curing recurrent aphthous ulcer |
| 02/20/2013 | CN102935087A Compound electrolyte injection composition and preparation method thereof |
| 02/20/2013 | CN102935085A Hemostatic drug formulation for cock castration operation |
| 02/20/2013 | CN102935084A Compound ivermectin sustained release tablet and preparation method thereof |
| 02/20/2013 | CN102935083A Application of phenylethanoid glycoside monomer compounds |
| 02/20/2013 | CN102935082A Drug for external use for preventing and treating scabies |
| 02/20/2013 | CN102935081A Dipeptidyl peptidase inhibitors for treating diabetis |
| 02/20/2013 | CN102935080A Bendamustine cyclopolysaccharide compositions |
| 02/20/2013 | CN102935079A Pharmaceutical application of caffeic acid 3, 4-dihydroxyl phenethylester |
| 02/20/2013 | CN102935078A Ibuprofen oral dispersing film agent |
| 02/20/2013 | CN102935077A Bionic lovastatin nano-structured lipid carrier and preparation method thereof |
| 02/20/2013 | CN102935076A Capsule containing atorvastatin sodium and preparation method thereof |
| 02/20/2013 | CN102935075A 头孢地尼胶囊及其制备方法 Cefdinir capsules and its preparation method |
| 02/20/2013 | CN102935074A Trazodone hydrochloride osmotic pump controlled release tablet |
| 02/20/2013 | CN102935073A Glimepiride dispersible tablet and preparation method thereof |
| 02/20/2013 | CN102935072A Lansoprazole tablet and preparation method thereof |
| 02/20/2013 | CN102935071A Venlafaxine hydrochloride controlled-release pellet and preparation method thereof |
| 02/20/2013 | CN102935066A Irinotecan liposome preparation and preparation method thereof |
| 02/20/2013 | CN102935065A Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 02/20/2013 | CN102935064A Aspartic acid lomefloxacin injection preparation and preparation method thereof |
| 02/20/2013 | CN102935063A Acetyl dithranol paste and preparation method thereof |
| 02/20/2013 | CN102935062A Polymeric micelle composition loaded with epothilone compound or derivatives thereof, freezed-drying preparation, and preparation and application thereof |
| 02/20/2013 | CN102349916B Ceforanide C-type crystal composition used for injection and its preparation method |
| 02/20/2013 | CN102335250B Health-care product used for treating initial infection of foot-and-mouth disease of sow |
| 02/20/2013 | CN102302508B Composition for treating skin itch |
| 02/20/2013 | CN102302442B Allicin vaginal suppository and preparation method thereof |
| 02/20/2013 | CN102294031B Pharmaceutical formulation comprising proton pump inhibitor, NSAID and antacids |
| 02/20/2013 | CN102293741B Bromhexine hydrochlorie injection, its preparation method and application |
| 02/20/2013 | CN102274303B Traditional Chinese medicine extract compound injection for treating yellow-white dysentery of piglets and preparation method |
| 02/20/2013 | CN102266299B Composition chewing tablets for a zinc gluconate compound and preparation method thereof |
| 02/20/2013 | CN102225097B Application of extract of Rheum emodi Wall. in preparing anti-fibrosis drug |
| 02/20/2013 | CN102198125B Purpose of phenethyl caffeate derivatives in preparation of medicines for inhibiting angiogenesis of tumors |
| 02/20/2013 | CN102172348B Solid oseltamivir phosphate medicinal composition |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN102138913B Ranitidine hydrochloride capsules and production method thereof |
| 02/20/2013 | CN102086197B Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 02/20/2013 | CN102048709B Gentamycin sulfate capsule and preparation method thereof |
| 02/20/2013 | CN102046164B Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders |
| 02/20/2013 | CN102038952B Composition for improving the viability of nerve cells and use of the composition |
| 02/20/2013 | CN102008715B Antitumor MA-TNF alpha medicine composition and application thereof |
| 02/20/2013 | CN102008710B Lisinopril-containing compound preparation for treating hypertension |
| 02/20/2013 | CN102008708B Ramipril-contained compound preparation for treating hypertension |
| 02/20/2013 | CN101987094B Ornithine aspartate injection and preparation method thereof |
| 02/20/2013 | CN101874031B Sirtuin modulating imidazothiazole compounds |
| 02/20/2013 | CN101849675B Dietary supplements containing natural ingredients |
| 02/20/2013 | CN101838213B Method for preparing laminine and pharmaceutically acceptable salts thereof |
| 02/20/2013 | CN101836962B Method for preparing bendamustine hydrochloride freeze-dried powder injection |
| 02/20/2013 | CN101829044B Tamibarotene solid preparation and preparation method thereof |
| 02/20/2013 | CN101773490B Active part of Sambucus williamsii Hance for reducing risk of bone-related diseases of menopausal women and application thereof |
| 02/20/2013 | CN101772489B Amine salts of a CRTH2 antagonist |
| 02/20/2013 | CN101703488B Two-layer osmotic pump controlled release tablet with lubricating layer structure and preparation method thereof |
| 02/20/2013 | CN101679442B Compounds for the treatment of hepatitis c |
| 02/20/2013 | CN101679427B Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 02/20/2013 | CN101669970B Method for microwave extracting fat-soluble toad venom by using toad skin |
| 02/20/2013 | CN101595094B Cycloalkylamine substituted isoquinolone derivatives |
| 02/20/2013 | CN101584663B Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof |
| 02/20/2013 | CN101563084B 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 02/20/2013 | CN101554386B Medicine composition for curing hepatic disease and preparation method thereof |
| 02/20/2013 | CN101541789B Hydantoin derivatives used as mmp inhibitors |
| 02/20/2013 | CN101534792B Granule and orally disintegrating tablet comprising oxycodone |
| 02/20/2013 | CN101495110B Compositions and methods useful for treatment of respiratory illness |
| 02/20/2013 | CN101472477B IL-8 receptor antagonists |
| 02/20/2013 | CN101454008B Dental appliance cleanser |
| 02/20/2013 | CN101351451B Multicyclic amino acid derivatives and methods of their use |
| 02/20/2013 | CN101292020B A process for the removal of sterols and other compounds from glycerol oils |
| 02/20/2013 | CN101277700B Pyrimidine compounds as serotonin receptor modulators |
| 02/19/2013 | USRE44017 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 02/19/2013 | US8378118 Pyrazole-based thyroid receptor compounds |
| 02/19/2013 | US8378114 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same |
| 02/19/2013 | US8378112 Glycyrrhetinic acid derivative and use thereof |
| 02/19/2013 | US8378108 Apoptosis signal-regulating kinase inhibitors |
| 02/19/2013 | US8378102 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods |
| 02/19/2013 | US8378100 Phosphonate derivatives as autotaxin inhibitors |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8378097 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist |